Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 May 24;10(3):154–161. doi: 10.1159/000539434

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2024 The Author(s). Published by S. Karger AG, Basel

This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.

PMC Copyright notice

Fig. 1. — Response to belzutifan in a patient with VHL-associated bilateral RHs. Right eye (a) and left eye (b) show color fundus photographs and optical coherence tomography (OCT) of a patient with bilateral optic disc angiomas with associated cystoid macular edema that had been treated with a combination of PDT laser, focal laser, intravitreal anti-VEGF, and intravitreal and subtenon’s steroids to both eyes and external beam radiation to the right eye. Right eye (c) and left eye (d) show color fundus photographs and OCT images of the patient after 9 months of treatment with systemic belzutifan with regression of the tumors and marked improvement in the cystoid macular edema on OCT.